Department of Cardiology

Medicine & Life Sciences

1. Coronary Vessels 100%
2. Coronary Artery Disease 99%
3. Cardiovascular Diseases 89%
4. Heart Failure 87%
5. Calcium 71%
6. Atherosclerosis 67%
7. Mortality 67%
8. Myocardial Infarction 66%
9. Computed Tomography Angiography 49%
10. Echocardiography 48%
11. Registries 46%
12. Hydroxymethylglutaryl-CoA Reductase Inhibitors 45%
13. Lipids 44%
14. Transcatheter Aortic Valve Replacement 44%
15. Percutaneous Coronary Intervention 40%
16. Heart 39%
17. Therapeutics 38%
18. Heart-Assist Devices 37%
19. Coronary Disease 36%
20. Cholesterol 35%
21. Lipoproteins 33%
22. Exercise 32%
23. Aortic Valve 30%
24. Hypertension 28%
25. Atrial Fibrillation 28%
26. Magnetic Resonance Spectroscopy 28%
27. Acute Coronary Syndrome 28%
28. LDL Cholesterol 28%
29. Blood Pressure 27%
30. HDL Lipoproteins 27%
31. Confidence Intervals 27%
32. Population 26%
33. LDL Lipoproteins 26%
34. Tomography 25%
35. Angiography 25%
36. Stroke 25%
37. Hypertrophic Cardiomyopathy 24%
38. Coronary Angiography 24%
39. Mitral Valve Insufficiency 24%
40. Cardiomyopathies 23%
41. Mitral Valve 23%
42. Left Ventricular Function 23%
43. Cardiology 23%
44. Myocardial Perfusion Imaging 23%
45. Stroke Volume 23%
46. Platelet Glycoprotein GPIIb-IIIa Complex 22%
47. Guidelines 22%
48. Apolipoproteins 21%
49. Heart Transplantation 21%
50. Meta-Analysis 21%
51. Hemodynamics 21%
52. HDL Cholesterol 21%
53. Placebos 20%
54. Cardiac Arrhythmias 20%
55. Single-Photon Emission-Computed Tomography 20%
56. Aortic Valve Stenosis 20%
57. Apolipoprotein A-I 20%
58. Perfusion 20%
59. Odds Ratio 20%
60. Safety 19%
61. Risk Assessment 19%
62. Thrombosis 19%
63. Primary Prevention 18%
64. Equipment and Supplies 18%
65. Myocardium 18%
66. Transplants 18%
67. Myocardial Ischemia 17%
68. Magnetic Resonance Imaging 17%
69. Ventricular Tachycardia 17%
70. Abciximab 17%
71. Health 17%
72. Blood Platelets 17%
73. Incidence 16%
74. Stents 16%
75. Heart Diseases 16%
76. Heart Ventricles 16%
77. Aspirin 16%
78. Triglycerides 16%
79. Ischemia 15%
80. Apolipoproteins B 15%
81. Randomized Controlled Trials 15%
82. Atherosclerotic Plaques 15%
83. Thallium-201 15%
84. Surgical Instruments 15%
85. Systematic Reviews 14%
86. Fibrosis 14%
87. Dilated Cardiomyopathy 14%
88. Coronary Artery Bypass 14%
89. Pressure 14%
90. Apoproteins 14%
91. Heparin 14%
92. Drug-Eluting Stents 14%
93. Chest Pain 14%
94. Clinical Trials 14%
95. Pathologic Constriction 14%
96. Type 2 Diabetes Mellitus 14%
97. Infarction 13%
98. Delivery of Health Care 13%
99. Hemorrhage 13%
100. Multicenter Studies 13%